Loading...
XNYS
AVNS
Market cap1.17bUSD
Jul 09, Last price  
24.94USD
1D
0.08%
1Q
75.88%
Jan 2017
-32.56%
IPO
-37.26%
Name

Avanos Medical Inc

Chart & Performance

D1W1MN
XNYS:AVNS chart
P/E
P/S
1.67
EPS
Div Yield, %
Shrs. gr., 5y
-0.59%
Rev. gr., 5y
-0.38%
Revenues
701m
+1.95%
1,659,900,0001,684,000,0001,677,500,0001,672,100,0001,574,400,000566,200,000611,600,000652,300,000697,600,000714,800,000744,600,000684,100,000673,300,000687,800,000701,200,000
Net income
-68m
L-82.68%
142,400,000152,600,000154,600,00027,100,000-426,300,00039,800,00079,300,00057,500,000-45,900,000-27,200,0006,300,00050,500,000-61,800,000-392,100,000-67,900,000
CFO
75m
-25.82%
139,600,000202,600,000223,800,000147,900,00097,600,000188,800,000144,200,000-145,600,000-74,500,000-2,500,00087,300,00090,900,00032,400,000100,700,00074,700,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Avanos Medical, Inc. is a pioneering medical technology enterprise dedicated to furnishing device solutions across a broad international footprint, encompassing North America, Europe, the Middle East, Africa, the Asia Pacific region, and Latin America. Its comprehensive product array targets two primary areas: chronic care and non-opioid pain management. Within chronic care, the company provides digestive health offerings such as Mic-Key enteral feeding tubes, Corpak patient feeding systems, and NeoMed solutions tailored for neonatal and pediatric patients. Its respiratory health segment includes closed airway suction systems and other airway management devices, marketed under prominent brands like Ballard, Microcuff, and Endoclear. For non-opioid pain relief, Avanos offers acute pain solutions, including On-Q and ambIT surgical pain pumps, along with Game Ready cold and compression therapy systems. It also features interventional pain solutions, providing minimally invasive therapies like Coolief for long-term pain alleviation. The company facilitates product access by selling directly to hospitals, various healthcare providers, and end-user facilities, in addition to utilizing third-party wholesale distributors. Originally incorporated in 2014 and known as Halyard Health, Inc., the company officially adopted the name Avanos Medical, Inc. in June 2018 and maintains its headquarters in Alpharetta, Georgia.
IPO date
Oct 21, 2014
Employees
4,044
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT